![](https://www.lachmanconsultants.com/wp-content/themes/lac/wp-content/uploads/2023/02/missing-thumbnail.jpg)
This Road Has Been Traveled Before? Chance of Success Approaching Zero!
IntelGenx Corporation of Saint Laurent, Quebec, Canada submitted petition FDA-2013-P-1058 (here) on August 22, 2013, asking the FDA to designate its Rizatriptan Oral Film product as AB rated (or therapeutically equivalent [TE]) when approved to Maxalt-MLT Orally Disintegrating Tablets, the reference listed drug (RLD) cited in its 505(b)(2) application. The fact that the two products might perform similarly does not overcome the fact that the products are different dosage forms.